These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20221868)

  • 1. Paraoxonase 1 status as a risk factor for disease or exposure.
    Richter RJ; Jarvik GP; Furlong CE
    Adv Exp Med Biol; 2010; 660():29-35. PubMed ID: 20221868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human PON1, a biomarker of risk of disease and exposure.
    Furlong CE; Suzuki SM; Stevens RC; Marsillach J; Richter RJ; Jarvik GP; Checkoway H; Samii A; Costa LG; Griffith A; Roberts JW; Yearout D; Zabetian CP
    Chem Biol Interact; 2010 Sep; 187(1-3):355-61. PubMed ID: 20338154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
    Costa LG; Richter RJ; Li WF; Cole T; Guizzetti M; Furlong CE
    Biomarkers; 2003; 8(1):1-12. PubMed ID: 12519632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 1 (PON1) status and substrate hydrolysis.
    Richter RJ; Jarvik GP; Furlong CE
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):1-9. PubMed ID: 19071155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
    Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
    Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
    Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
    Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
    Mutch E; Daly AK; Williams FM
    Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
    Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
    Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone.
    Teiber JF; Horke S; Haines DC; Chowdhary PK; Xiao J; Kramer GL; Haley RW; Draganov DI
    Infect Immun; 2008 Jun; 76(6):2512-9. PubMed ID: 18347034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1.
    Stoltz DA; Ozer EA; Taft PJ; Barry M; Liu L; Kiss PJ; Moninger TO; Parsek MR; Zabner J
    J Clin Invest; 2008 Sep; 118(9):3123-31. PubMed ID: 18704198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
    Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
    Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PON1 gene and detoxication.
    Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
    Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-environmental interactions and organophosphate toxicity.
    Povey AC
    Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
    Albers JW; Garabrant DH; Berent S; Richardson RJ
    J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.
    Coombes RH; Meek EC; Dail MB; Chambers HW; Chambers JE
    Toxicol Lett; 2014 Oct; 230(1):57-61. PubMed ID: 25093614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
    Furlong CE
    J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
    Costa LG; Giordano G; Cole TB; Marsillach J; Furlong CE
    Toxicology; 2013 May; 307():115-22. PubMed ID: 22884923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.